215 related articles for article (PubMed ID: 7833469)
21. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias.
Ogawa S; Hirano N; Sato N; Takahashi T; Hangaishi A; Tanaka K; Kurokawa M; Tanaka T; Mitani K; Yazaki Y
Blood; 1994 Oct; 84(8):2431-5. PubMed ID: 7919362
[TBL] [Abstract][Full Text] [Related]
22. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias.
Hebert J; Cayuela JM; Berkeley J; Sigaux F
Blood; 1994 Dec; 84(12):4038-44. PubMed ID: 7994022
[TBL] [Abstract][Full Text] [Related]
23. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer.
Williamson MP; Elder PA; Shaw ME; Devlin J; Knowles MA
Hum Mol Genet; 1995 Sep; 4(9):1569-77. PubMed ID: 8541841
[TBL] [Abstract][Full Text] [Related]
24. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
Tahara H; Smith AP; Gaz RD; Arnold A
J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
[TBL] [Abstract][Full Text] [Related]
25. Alterations of cyclin-dependent kinase 4 inhibitor (p16INK4A/MTS1) gene structure and expression in acute lymphoblastic leukemias.
Delmer A; Tang R; Senamaud-Beaufort C; Paterlini P; Brechot C; Zittoun R
Leukemia; 1995 Jul; 9(7):1240-5. PubMed ID: 7630199
[TBL] [Abstract][Full Text] [Related]
26. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia.
Sill H; Goldman JM; Cross NC
Blood; 1995 Apr; 85(8):2013-6. PubMed ID: 7718873
[TBL] [Abstract][Full Text] [Related]
27. P16INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9.
Faienza MF; della Ragione F; Basso G; Coppola B; Miraglia del Giudice E; Schettini F; Iolascon A
Br J Haematol; 1996 Jun; 93(3):632-6. PubMed ID: 8652384
[TBL] [Abstract][Full Text] [Related]
28. Analysis of p16 gene deletion and point mutation in breast carcinoma.
Quesnel B; Fenaux P; Philippe N; Fournier J; Bonneterre J; Preudhomme C; Peyrat JP
Br J Cancer; 1995 Aug; 72(2):351-3. PubMed ID: 7640217
[TBL] [Abstract][Full Text] [Related]
29. p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
Cheng JQ; Jhanwar SC; Klein WM; Bell DW; Lee WC; Altomare DA; Nobori T; Olopade OI; Buckler AJ; Testa JR
Cancer Res; 1994 Nov; 54(21):5547-51. PubMed ID: 7923195
[TBL] [Abstract][Full Text] [Related]
30. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda Y; Yoshimoto T; Sekiya T
Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
[TBL] [Abstract][Full Text] [Related]
32. Deletions and rearrangement of CDKN2 in lymphoid malignancy.
Stranks G; Height SE; Mitchell P; Jadayel D; Yuille MA; De Lord C; Clutterbuck RD; Treleaven JG; Powles RL; Nacheva E
Blood; 1995 Feb; 85(4):893-901. PubMed ID: 7849311
[TBL] [Abstract][Full Text] [Related]
33. p16ink4a gene and hematological malignancies.
Quesnel B; Preudhomme C; Fenaux P
Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
[TBL] [Abstract][Full Text] [Related]
34. p16INK4A and p15INK4B gene deletions in primary leukemias.
Haidar MA; Cao XB; Manshouri T; Chan LL; Glassman A; Kantarjian HM; Keating MJ; Beran MS; Albitar M
Blood; 1995 Jul; 86(1):311-5. PubMed ID: 7795238
[TBL] [Abstract][Full Text] [Related]
35. Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.
Siebert R; Willers CP; Schramm A; Fosså A; Dresen IM; Uppenkamp M; Nowrousian MR; Seeber S; Opalka B
Br J Haematol; 1995 Oct; 91(2):350-4. PubMed ID: 8547074
[TBL] [Abstract][Full Text] [Related]
36. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
Southgate J; Proffitt J; Roberts P; Smith B; Selby P
Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470
[TBL] [Abstract][Full Text] [Related]
37. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma.
Elenitoba-Johnson KS; Gascoyne RD; Lim MS; Chhanabai M; Jaffe ES; Raffeld M
Blood; 1998 Jun; 91(12):4677-85. PubMed ID: 9616165
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
39. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR
Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033
[TBL] [Abstract][Full Text] [Related]
40. Homozygous deletions of the CDKN2 (MTS1/p16ink4) gene in cell lines established from children with acute lymphoblastic leukemia.
Zhou M; Gu L; James CD; He J; Yeager AM; Smith SD; Findley HW
Leukemia; 1995 Jul; 9(7):1159-61. PubMed ID: 7630190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]